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Redirecting retroviral vector transduction simply by insertion of a ligand into the envelope (Env) protein has met with
several obstacles. For example, virions targeted to epidermal growth factor receptor (EGFR), after receptor binding, rapidly
traffic to the lysosomes, where they are degraded. Exotoxin A of Pseudomonas aeruginosa has the ability to translocate from
endosomes to the cytoplasm by means of a translocation domain (TLD). We generated a series of chimeric Env proteins of
Moloney murine leukemia virus containing EGFR ligands, where TLD was inserted into different regions. These chimeric
proteins were successfully produced, if the translocation domain was not located at the immediate N-terminus of Env. The
ability to transduce murine cells via the ecotropic receptor varied but correlated with the amount of Env proteins incorporated
into the virions. Chimeric vector particles could bind to EGFR, demonstrating the functional exposure of the peptide ligand.INTRODUCTION
An important prerequisite for retrovirus-based in vivo
gene therapy protocols is the development of vectors
that are able to bind to specific receptors on human cells
and enter those cells in a targeted fashion.
The 170-kDa epidermal growth factor receptor (EGFR)
is a member of the ErbB family, which belongs to the
superfamily of receptor tyrosine kinases, playing an im-
portant role in development. Many tumors of epithelial
origin, including cancers of the lung, breast, head and
neck, and bladder, show overexpression of EGFR on
their surface, which is associated with poor prognosis
(Gullick, 1991; Veale et al., 1987; Slamon et al., 1987;
Olayioye et al., 2000). Upon binding of ligands such as
epidermal growth factor (EGF) or transforming growth
factor-alpha (TGF), the formation of homo- and het-
erodimers with other ErbB receptors occurs. An intrinsic
tyrosine kinase activity leads to autophosphorylation at
specific tyrosine residues within the cytoplasmic domain
of EGFR, which, in turn, leads to the activation of intra-
cellular signaling pathways. Activated EGFR is sorted
into clathrin-coated pits. Despite similar binding affini-
ties, EGF and TGF show different biological activities
due to different processing in the endosomal compart-
ment once the respective ligand–receptor complex has
been internalized. Ligands such as EGF, with a relatively333pH-resistant interaction, target the receptor to the lyso-
somes for degradation, whereas TGF easily dissociates
at endosomal pH, resulting in receptor recycling (French
et al., 1995; Waterman et al., 1998). Because of the high
expression on a variety of cancer cells coupled with the
location at the surface of the cell, EGFR constitutes an
attractive target to specifically transduce cancer cells
while leaving normal cells unaffected.
Moloney murine leukemia virus (Mo-MLV) is an onco-
virus that enters the target cell through an interaction of
its envelope glycoprotein (Env) with the ecotropic recep-
tor mCAT-1, a cationic amino acid transporter (Albritton et
al., 1989). Env is synthesized as an 85-kDa precursor of
635 amino acids (aa) in length carrying a leader peptide
of 33 aas at its N-terminus, which directs the protein to
the endoplasmic reticulum and is cleaved off after syn-
thesis. Env undergoes a series of posttranslational mod-
ifications, including glycosylation, oligomerization, and
the formation of disulfide bonds. In addition, a cellular
protease cleaves Env into the external surface (SU) and
the membrane-spanning transmembrane (TM) subunits
(Hunter, 1997). On the viral surface, Env exists as a trimer
(Einfeld and Hunter, 1988; Kamps et al., 1991) and inter-
acts with mCAT-1 through its SU fragment. Upon binding,
the Env molecule undergoes a conformational change
which, in a reaction that is not completely understood,
leads to the fusion of viral and cellular membranes,
allowing the virus to be internalized and begin the infec-However, transduction of human cells expressing EGFR
protein was not observed. © 2002 Elsevier Science (USA)
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serve as a receptor for Mo-MLV and human cells are
resistant to Mo-MLV infection. Attempts have been made
to redirect the host range of Mo-MLV-based vectors to
specific receptors present on human cells by inserting a
variety of ligands, including EGF, into Mo-MLV Env. How-
ever, this resulted in inefficient or undetectable transduc-
tion levels even though specific binding to the receptor
could be demonstrated (Schnierle and Groner, 1996;
Benedict et al., 1999; Zhao et al., 1999; Cosset and Rus-
sell, 1996). The failure to transduce human cells has
been partly explained by the fact that after binding to the
receptor, the retargeted Mo-MLV vectors become inter-
nalized and routed to the endosomes, where they are
degraded (Cosset et al., 1995; Zhao et al., 1999).
Exotoxin A (ETA) of Pseudomonas aeruginosa is a
66-kDa protein of 613 amino acids which consists of
three functional domains, as based on crystal structure
and deletion analysis (Allured et al., 1986; Hwang et al.,
1987). An N-terminal domain is responsible for the inter-
action with mammalian cells, using the low-density li-
poprotein receptor-related protein for endocytic uptake.
This domain is followed by an internal translocation
domain (TLD) and a C-terminal catalytic domain. Upon
internalization, ETA is cleaved by furin in an acidic en-
docytotic compartment within the translocation domain
between aa 279 and 280. This results in an N-terminal
28-kDa and a C-terminal 37-kDa fragment that are co-
valently linked by the Cys265–287 disulfide bond (Ogata
et al., 1992; Taupiac et al., 1996; Avramoglu et al., 1998;
FitzGerald et al., 1995; Kounnas et al., 1992). After reduc-
tion of the disulfide bond the C-terminal fragment trans-
locates to the cytoplasm, where it inactivates eukaryotic
elongation factor 2, leading to cessation of protein syn-
thesis and cell death (Pastan and FitzGerald, 1989; Brink-
mann et al., 1995, 1996). Recently, it has been shown that
this TLD could facilitate endosomal escape function in
chimeric proteins. In these experiments, the natural cell-
binding domain at the N-terminus of ETA was exchanged
for the ligand TGF. Likewise, the C-terminal catalytic
domain was replaced with the DNA-binding domain of
the yeast transcription factor GAL4 (Fominaya et al.,
1998). The resulting chimeric protein displayed specific
binding to EGFR-expressing cells and was able to trans-
fect these cells in vitro.
Here, we report the insertion of the ETA translocation
domain into several regions of the EGFR-targeting eco-
tropic Env protein to investigate the release of endo-
some-targeted retroviral particles into the cytoplasm. We
studied the expression and the incorporation of these
chimeric Env proteins into virions and their ability to
transduce cells of murine or human origin. We also
introduced mutations into the backbone of Env which
have been described to play an important role in the
fusion process and improve vector association of the
respective proteins (Zavorotinskaya and Albritton, 1999,
2001). The results show that the chimeric proteins could
successfully bind to EGFR and that transduction of
mouse cells correlated with the incorporation of the
fusion proteins into the virions. However, transduction of
COS-7 or A431 cells, expressing EGFR but not mCAT-1,
could not be observed, indicating that the presence of
the translocation domain is not sufficient to allow endo-
some-trapped viral particles to escape from degradation.
RESULTS
Comparison of EGF and TGF as ligands in chimeric
proteins
EGF and TGF constitute natural ligands for EGFR
with similar binding affinities. However, due to different
processing of the respective ligand–receptor complex in
the endosomal compartment, they exhibit different bio-
logical activities (Ebner and Derynck, 1991; Lenferink et
al., 1997). We fused 53 aa of EGF and 64 aa of TGF
N-terminally to Mo-MLV Env to investigate possible dif-
ferences in their transduction efficiency when used as
ligands in chimeric proteins (Fig. 1). Plasmids coding for
these chimeric proteins were transiently transfected into
the human packaging cell line Anjou 65 (Pear et al.,
1993), together with pSFG-EGFP, a retroviral vector con-
struct encoding the enhanced green fluorescence pro-
tein (Lindemann et al., 1997). In these transient transfec-
tion experiments, wt(HX) usually achieved a transduction
titer of 104 colonies per ml. When the chimeric Env
constructs were tested for their ability to transduce
mouse NIH3T3 cells via the ecotropic receptor mCAT-1,
we found that the insertion of the ligand reduced the
transduction titer when compared with wt(HX). However,
with 30% of the wt(HX) titer, EGF-Env was more active
than TGF-Env, which yielded a transduction efficiency
of 2% (Fig. 1). In Western blot analysis we then studied
the production and packaging of the respective proteins.
It was found that in the cellular lysate, the recombinant
proteins were present to similar amounts (Fig. 2, lanes 2
and 3). The supernatant of the producer cells was then
collected and pelleted through a 30% sucrose cushion.
Here, it became evident that EGF-Env was packaged
more efficiently into virions than TGF-Env (Fig. 2, lanes
5 and 6). These data demonstrate that, as part of a
chimeric Env protein, EGF is more suitable as a ligand
than TGF, despite a similar length.
Positioning effects of the TLD sequences in the
chimeric proteins
In the ETA molecule, the TLD has been defined to be
located between aa positions 253 and 366, with the
receptor-binding domain at the N-terminus and the cat-
alytic domain at the C-terminus. To investigate its influ-
ence on transduction efficiency, we inserted aa 252–366
into EGF-Env and TGF-Env behind the ligand, generat-
ing the constructs EGF-TLD-Env and TGF-TLD-Env, re-
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spectively (Fig. 1). We found that the presence of TLD
further decreased the transduction titer to 6% of the
wt(HX) titer for EGF-TLD-Env and 0.5% for TGF-TLD-Env
(Fig. 1).
Recent studies that examined which regions of Env
were suitable for insertions described that foreign pep-
tides are well tolerated and exposed when cloned into
the proline-rich region (PRR; aa 230–275 of Env) within
the SU domain of Env (Kayman et al., 1999; Wu et al.,
2000). To investigate whether this region also tolerated
the insertion of the TLD sequences, we generated
EGF(TLD/PRR), where the TLD is located in the PRR of
the EGF-Env protein (Fig. 1). After transfection, EGF(TLD/
PRR) was produced in similar amounts as the other
TLD-containing chimeric proteins by Anjou 65 cells (Fig.
3A, lane 5). However, when virions were analyzed by
Western blot, no specific band was detectable for
EGF(TLD/PRR) (Fig. 3B, lane 5). In transduction experi-
ments, the resulting titer on NIH3T3 cells was 3% of wt
(Fig. 1). This indicated that the chimeric Env protein had
FIG. 1. Schematic representation of the Mo-MLV Env proteins designed to target EGFR expressing cells and their relative ability to transduce mouse
NIH3T3 cells. In wt(HX), HindIII and XhoI sites have been engineered into env between the sequence for the leader peptide and the N-terminus of
the mature Env protein (B. S. Schnierle, unpublished observations), which are not present in the original Mo-MLV env gene. The location of the ligand
sequences (EGF or TGF) and the TLD in different regions of the Env protein is shown. Important restriction sites used for cloning are indicated. B,
BamHI; H, HindIII; N, NotI, P, PflMI; Sf, SfiI; Sg, SgrAI; X, XhoI. L, Leader peptide. Transducing titers of the respective vectors bearing the chimeric Env
proteins in respect to wt(HX) Env. Standard derivations of three independent experiments are given.
FIG. 2. Analysis of the amount of EGF-Env and TGF-Env proteins
present in the cells (lanes 1–3) and in vector particles (lanes 4–6) by
Western blotting, as described under Materials and Methods. M, mo-
lecular weight standards. Positions of the precursor protein (SU/TM)
and the surface domain (SU) are indicated.
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retained its function and that the low titer was probably
the result of its low level of incorporation into virions.
In another experiment we were interested to see
whether the positioning of the TLD sequences in respect
to the EGF ligand could influence the production of the
resulting protein and its ability to transduce mouse
NIH3T3 cells. For this, we cloned a shortened form of
TLD, TLDs, in front of or behind EGF, generating EGF-
TLDs-Env and TLDs-EGF-Env (Fig. 1). TLDs encodes aa
280 to 366 of the translocation domain, but lacks the furin
cleavage site present between aa 279 and 280 of the
complete TLD. In addition, the cysteine residue at posi-
tion 287 of ETA, forming a disulfide bridge with Cys 265
in the complete TLD, has been replaced by a serine
residue (Ogata et al., 1992). However, TLDs is still able to
translocate into the cytoplasm (Theuer et al., 1993). In
construct EGF-TLDs-Env, the shortened TLD is located
behind the EGF ligand, similar to EGF-TLD-Env. However,
at 12% of wt, the transduction efficiency was higher for
construct EGF-TLDs-Env than for EGF-TLD-Env (6% of
wt(HX), Fig. 1). There was also more virus-associated
EGF-TLDs-Env protein than EGF-TLD-Env. This indicated
that the N-terminus of TLD carries sequences that neg-
atively influence incorporation into virions.
When the TLDs sequence was cloned in front of EGF
(construct TLDs-EGF-Env), no distinct protein was de-
tectable in the cellular lysate by Western blot analysis
(Fig. 3A, lane 7) and no transduction was observed.
Integrity of the construct was confirmed by DNA se-
quencing (data not shown). To investigate whether the
location of the TLDs sequence at the immediate N-
terminus of the Env protein was responsible for the lack
of expression, we deleted the EGF sequence from the
construct EGF-TLDs-Env. This moved the TLDs sequence
to the very beginning of the mature Env protein, yielding
TLDs-Env. Again, no protein was detected and the trans-
duction of NIH3T3 cells failed (Fig. 1). Another protein,
carrying the complete TLD at the N-terminus of Env, was
also not detected in Western blot analysis and could not
transduce mouse NIH3T3 cells (B. Schnierle, unpub-
lished results). These data indicate that the TLD se-
quences are not tolerated at the immediate N-terminus
of Env.
Stabilizing modifications of the Env sequences
Recently, a report described that modification of two
positions (Q227R and D243Y) in a hybrid Env protein
containing amphotropic and ecotropic sequences (con-
struct ampho-ecoQ227R D243Y Env) stabilizes the as-
sociation of this protein with the virion and enhances
transduction of target cells (Zavorotinskaya and Albritton,
1999, 2001). To investigate whether this double mutation
could also help to increase the transduction titer of the
chimeric Env proteins containing the TLD sequences, we
introduced these modifications into the Env backbone of
several constructs. This was done for constructs EGF-
Env, EGF-TLDs-Env, and EGF(TLD/PRR), resulting in the
chimeric proteins EGF-EnvM1, EGF-TLDs-EnvM1, and
EGF(TLD/PRRM1), respectively (Fig. 1). When the virions
of the supernatant were analyzed on immunoblots, the
mutants EGF-EnvM1 and EGF-TLDs-EnvM1 gave a
slightly stronger signal than the original constructs. No
band could be detected for the mutant EGF(TLD/PRRM1)
(Fig. 4). On NIH3T3 cells, however, an increase in the
transduction titer was found only for EGF-TLDs-EnvM1
FIG. 4. Western blot analysis of M1 Env protein mutants carrying the
Q227R, D243Y double mutation in comparison with their unmodified
parental proteins. Cell lysates and vector particles were analyzed. M,
molecular weight standards. The position of the envelope protein
surface domain (SU) is indicated with an asterisk.
FIG. 3. Western blot analysis of the production and vector associa-
tion of chimeric Env proteins. (A) Cellular lysate; (B) vector particles. M,
molecular weight standards. The positions of the precursor protein
(SU/TM) are indicated by asterisks.
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(Fig. 1), whereas no clear beneficial effect could be
detected for EGF-EnvM1 or EGF(TLD/PRRM1).
Binding of the chimeric proteins to EGFR
We wanted to investigate whether the presence of the
TLD sequences still allowed binding of the chimeric
proteins to EGFR. For this, we incubated EGFR-express-
ing COS-7 cells with supernatants produced from Anjou
65 cells that had been transfected with pEGF-Env or
pEGF-TLDs-Env to see whether these fusion proteins
could activate the receptor. Upon binding, EGFR be-
comes phosphorylated at tyrosine residues, which can
be detected with an antiphosphotyrosine antibody. In a
positive control experiment, incubation of COS-7 cells
with recombinant EGF protein of murine origin (mEGF)
resulted in specific phosphorylation (Fig. 5, lane 2). This
could be blocked by incubation with anti-EGFR antibody
C225 (Fan and Mendelsohn, 1998) prior to exposure to
mEGF (lane 3). Specific phosphorylation of a protein
corresponding in size with the 170-kDa EGFR could also
be detected for the vector supernatants containing the
chimeric proteins EGF-Env and EGF-TLDs-Env (lanes 6
and 8). In these cases, preincubation with C225 also
blocked induction of phosphorylation by the respective
chimeric Env proteins (lanes 7 and 9). In contrast, vector
particles containing wt Env, which cannot bind to EGFR,
were not able to induce specific EGFR phosphorylation
(lane 4). Reprobing with an anti-EGFR antibody con-
firmed the position of phosphorylated EGFR (Fig. 5B).
When A431 cells expressing high amounts of EGFR were
assayed, a similar pattern of phosphorylation to that of
the COS-7 cells was observed (data not shown).
No transduction of EGFR expressing cells by vectors
carrying the chimeric proteins
We wanted to investigate whether the fusion proteins
containing the TLD sequences were able to transduce
EGFR-expressing cells of human or monkey origin. It has
been described that, after endocytosis, viruses targeted
to EGFR are directed to the endosomal pathway, where
they are trapped and finally degraded in the lysosomes
(Cosset et al., 1995). Since the TLD of ETA exerts its
activity in the acidic environment of the endosome, we
hoped that as part of the Env molecule the TLD would
help the virus to escape degradation and efficiently
transduce the recipient cells. For this, we transfected the
packaging cell line Anjou 65 with plasmids encoding the
chimeric proteins together with plasmid pSFG-EGFP.
Two days later, the supernatant was filtered and added
to COS-7 and A431 cells. Both cell lines express EGFR on
their surface, with A431 cells showing the higher expres-
sion when measured by FACS analysis with an anti-
EGFR antibody (data not shown). However, despite trans-
duction titers on NIH3T3 cells of up to 3  103 per ml for
EGF-TLDsEnv, no specific transduction of COS-7 cells or
A431 cells was observed, demonstrating that specific
transduction of these cells is not possible or that it is
reduced by a factor of at least 3  103. In combination
FIG. 5. Functional exposure of the EGF ligand in the chimeric Env proteins. COS-7 cells were exposed to virus supernatant of the respective
construct. C225 indicates preincubation of the COS-7 cells for 5 min with EGFR blocking antibody C225 before the virus was added. The position
of the 170-kDa EGFR is indicated. (A) Detection of phosphorylated EGFR by an antiphosphotyrosine antibody upon ligand binding. (B) Confirmation
of equal loading by reprobing of the membrane with a EGFR-specific antiserum.
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experiments we also cotransfected plasmids for two or
three different chimeric Env proteins into Anjou 65 cells.
This was done to generate a population of viruses which
display complexes of mixed Env trimers exposing the
TLD fragment in different regions of their Env molecules.
However, this approach did not enable transduction,
indicating that as a part of a chimeric Env protein, the
TLD sequences were not sufficient to rescue the vectors
from lysosomal degradation or that this event happens at
a rate reduced at least 3  103-fold compared to the
transduction efficiency of NIH3T3.
DISCUSSION
Here we studied whether ETA sequences are able to
rescue endosome-targeted retroviral vectors. First, we
investigated whether there was a difference between the
transduction efficiencies of chimeric Env proteins that
carried the receptor-binding domains of the EGFR li-
gands TGF and EGF at the N-terminus. Next, we in-
serted sequences of ETA comprising the TLD into differ-
ent regions of the Mo-MLV Env protein to see whether
the resulting chimeric proteins were functional and could
be incorporated into the virions. Finally, we investigated
whether the translocation domain-containing proteins
could confer to the resulting vector the ability to escape
the degradation process and allow efficient transduction
of human cells.
The results show that EGF-Env and TGF-Env were
produced in similar amounts in the cell. However, there
was more EGF-Env present in the virions than TGF-Env,
indicating that the ligand sequence influences incorpo-
ration of the modified protein into the vector particles.
The additional insertion of the TLD sequences of 115 aa
in length further decreased the titer for EGF-TLD-Env and
TGF-TLD-Env. Interestingly, EGF-TLD-Env gave a better
transduction efficiency than TGF-Env. This indicates
that it is the sequence of TGF itself, rather than the size
of the ligand (63 aa for TGF compared with 53 aa of
EGF), which is responsible for the decrease in incorpo-
ration and subsequently in the transduction efficiency.
We found that the position of the TLD within Env
drastically influenced the expression of the chimeric pro-
tein. For three constructs, where the TLD sequences
were located at the immediate N-terminus of Env, no
chimeric protein could be detected (constructs TLDs-
EGF-Env, TLDs-Env, and TLD-Env) and no transduction of
murine cells could be observed. This indicates that N-
terminally located, freely accessible TLD sequences in-
terfere with proper protein expression. In contrast to
these findings, the TLD seemed to be well tolerated
when present more to the middle of the respective pro-
tein, i.e., constructs EGF-TLD-Env, EGF-TLDs-Env, or
EGF(TLD/PRR). Within the ETA molecule, the TLD is sit-
uated in the middle of the toxin, between an N-terminal
receptor-binding domain and a C-terminal catalytic do-
main. This suggests that it is important to keep the
structural organization with the TLD sequences not ac-
cessible at the N-terminus of the chimeric proteins.
When present behind the ligand, the complete TLD and
the shorter TLDs were tolerated. The resulting chimeric
Env molecules were incorporated into vector particles
and they could transduce mouse cells (constructs EGF-
TLD-Env and EGF-TLDs-Env, respectively). This demon-
strates that the functionality of the Env backbone was
maintained.
Recently, a double mutation within Env (Q227R and
D243Y) has been described that increases targeted
transduction and stabilizes the association of Env with
the vector (Zavorotinskaya and Albritton, 2001). The au-
thors report that vector particles containing a chimeric
Env protein with amphotropic and ecotropic sequences
(ampho-eco Env) showed an increased transduction ef-
ficiency of up to 2000-fold when the Env protein carried
the double mutation (ampho-eco  Q227R D243Y Env).
We found a 1.5-fold increase in transduction of mouse
NIH3T3 cells for the construct EGF-TLDs-EnvM1 carrying
this double mutation over its parent EGF-TLDs-Env. An-
other mutant, EGF-EnvM1, did not show this effect over
the parent construct EGF-Env. This indicates that the
vector-stabilizing effect depends on each individual con-
struct. For the chimeric EGF(TLD/PRR) and the derived-
mutant EGF(TLD/PRRM1) the numbers were too small to
draw a clear conclusion.
The chimeric protein EGF(TLD/PRR) was well expressed
in the transfected cells yielding a functional protein of the
expected size. This indicates that the furin cleavage site
present in the TLD is not used during synthesis of the
protein, which otherwise might result in shorter, nonfunc-
tional Env fragments. However, EGF(TLD/PRR) is only mar-
ginally incorporated into the virions. Recently, the insertion
of peptides and even a single chain antibody of 252 aa into
the PRR and the efficient incorporation of these modified
proteins into virions have been described (Wu et al., 2000;
Kayman et al., 1999). The reason for the insufficient incor-
poration of EGF(TLD/PRR) into virions could be a result of
steric hindrance or improper folding of the Env molecule
due to the presence of the foreign TLD sequences. This
effect could not be overcome in construct EGF(TLD/
PRRM1), which carries the abovementioned Q227R, D243Y
double mutation.
In general, the results show that once the chimeric
proteins with the TLD sequences are synthesized, the
transduction efficiency correlates with their ability to be
packaged. However, since the shorter TLDs gave better
transduction results than the complete TLD, it seems that
the latter domain carries sequences that can adversely
affect packaging into virions. The presence of the TLD
sequences still allowed the EGF-containing chimeric
protein to bind to EGFR. This was demonstrated by the
detection of the specific phosphorylation of EGFR after
exposure to the chimeric Env-carrying vectors. However,
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specific transduction of COS-7 or human A431 cells
could not be observed. The reason for this is presently
not clear. At 104 colonies per ml for the construct wt(HX),
the vector titers in these transient transfection experi-
ments were rather low. Therefore, if the TLD of Pseudo-
monas exotoxin A works only at a much reduced activity
in the construct used here, transduction may take place,
but at a level too low to be detected. From the EGFR-
binding studies it appears that the N-terminus of the
chimeric proteins is well exposed and available for re-
ceptor binding. It appears possible that the surrounding
Env sequences prevent the TLD from folding into the
proper configuration to allow escape from the endo-
somes. Alternatively, complete virions may constitute
molecules too complex to be translocated across the
endosomal membrane. Taken together, host range ex-
tension of Mo-MLV Env is still not a suitable method to
target retroviral vectors. Mechanisms other than the bac-
terial TLD may need to be exploited to facilitate endoso-
mal release of viral vectors.
MATERIALS AND METHODS
Cell lines
Cells were grown in Dubecco’s modified Eagle’s medium
(Gibco, BRL, Karlsruhe, Germany) supplemented with 10%
fetal calf serum, 4 mM L-glutamine, 100 U/ml penicillin, and
100 g/ml streptomycin at 37°C in 5% CO2. The cell lines
used were NIH3T3, A431, COS-7, and 293T. The medium of
the packaging cell line Anjou 65, which provides MLV Gag
and Pol proteins (Pear et al., 1993), additionally contained
400 g/ml Hygromycin (Sigma).
Plasmids
All plasmid constructions were carried out using stan-
dard cloning procedures (Sambrook et al., 1989). Poly-
merase chain reaction (PCR) was carried out using Pfx
polymerase (Gibco-BRL) according to the manufacturer’s
instructions. Cycles were 30 s at 95°C, 1 min at 50°C, 1
min at 72°C. The primers used for PCR are shown in
Table 1. Oligonucleotides were purchased from MWG
Biotech, Ebersberg, Germany.
The Env expression plasmid pwt(HX) encodes for the
ecotropic Mo-MLV Env protein. As a modification from
the wild-type (wt) sequence, this plasmid includes
unique HindIII and XhoI sites for cloning in front of codon
1 of the sequence of the mature protein. As a conse-
quence, four additional aa (Lys, Leu, Leu, Glu), encoded
by these two sites, are present at the N-terminus of the
mature wt(HX) Env protein (B. S. Schnierle, unpublished
observations).
The plasmid pEGF-Env was created by PCR amplifica-
tion of the EGF sequence of pE-MO (Buchholz et al.,
1998), using the oligonucleotides 5EGF and 3EGF as
primers and inserting the amplicon between the HindIII
and XhoI sites of plasmid pwt(HX). During the cloning
procedure six additional nucleotides (ATGGCC, encod-
ing for aa Met, Ala) were incorporated immediately up-
stream of the EGF sequence. All derivatives of pEGF-Env
carry these additional six nucleotides.
To generate plasmid pEGF-TLD-Env, the sequence of
the P. aeruginosa exotoxin A translocation domain was
PCR amplified from a vector containing this sequence
(Fominaya et al., 1998), using 5ETA/NOT and 3ETA as
primers. The PCR product encoded aa 252 to 366 of ETA,
which includes the translocation domain, and was in-
serted between the NotI and XhoI sites of pEGF-Env.
In plasmid pEGF(TLD/PRR), the translocation domain
replaces the ecotropic env sequence between PflMI and
SgrAI in the proline-rich region (PRR). The TLD (Fomi-
naya et al., 1998) was PCR amplified using primers
5ETA/PRR and 3ETA/PRR.
TLDs represents a shortened fragment of TLD, encod-
ing aa positions 280 to 366 of ETA with the modifications
described by Theuer et al. (1993). This fragment is still
able to translocate but lacks the furin cleavage site. In
addition, Cys287 has been changed to Ser. To generate
plasmid pEGF-TLDs-Env, the TLDs sequence was PCR
amplified using primers 5ETAsNOT and 3ETA. The re-
sulting fragment was inserted between the NotI and XhoI
sites of pEGF-Env, downstream of the EGF sequences.
Plasmid pTLDs-EGF-Env was created by inserting the
TABLE 1
Oligonucleotides Used in the PCR
5TGF
5AGTACTAAGCTTGGTACCGGTGTGGTGTCC3
5EGF
5TTTTAAGCTTGCGGCCCAGCCGGCCAATAG3
3EGF
5TTTTCTCGAGTGCGGCCGCGCGCAGTTCCCACC3
5ETA/NOT
5TTTTGCGGCCGCAGAGGGCGGCAGCCTGGCCGCG3
3ETA
5TTTTCTCGAGGCTGGGGCGTCGACCAGCTTCTCGTCGGCGTTGGC
CG3
5ETA/PRR
5TTTTCCACCCAGTGGGGAGGGCGGCAGCCTGGCCGCGC3
3ETA/PRR
5TTTTCGCCGGTGGCAGCTTCTCGTCGGCGTTGGC3
5ETAsHIND
5TTTTAAGCTTGGCTGGGAACAACTGGAGCAG3
5ETAsNOT
5TTTTGCGGCCGCGGGCTGGGAACAACTGGAGCAG3
3ETAsSFI
5TTTTGGCCGGCTGGGCCTCGTCGGCGTTGGCCGCGCCGGC3
5Mlul
5GATCCGACTCAGATATCGAAATCTAGGACCACGCGTCCCAATAGG
GCCAAACCCCGTTCTGGCATACCAACAGCCACTCTCCAAGCCCAA
ACCTGTTAAGTCGCCTTCAGTCACCAAACCACCCA3
3Mlul
5GTGGTTTGGTGACTGAAGGCGACTTAACAGGTTTGGGCTTGGAGAG
TGGCTGTTGGTATGCCAGAACGGGGTTTGGCCCTATTGGGACGCG
GGGTCCTAGATTTCGATATCTGAGTCG3
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TLDs sequence between HindIII and SfiI, in front of EGF.
For this, the TLDs sequence was PCR amplified using
primers 5ETAsHIND and 3ETAsSFI.
To generate pTLDs-Env, the vector pEGF-TLDs-Env
was cut with NotI and HindIII, Klenow-treated, and re-
ligated to delete the EGF sequence.
The expression plasmid pTGF-Env was constructed
by cloning the sequence from HindIII to the blunt-ended
XhoI site of plasmid pSW50-TGF-ETA carrying the TGF
sequence (Schmidt and Wels, 1996) into the HindIII/
blunt-ended XhoI sites of plasmid pwt(HX), 5 to the env
sequence. For plasmid pTGF-TLD-Env, the TGF/TLD
sequences (Fominaya et al., 1998) was PCR amplified
using primers 5TGF and 3ETA and the amplicon was
inserted between the HindIII and XhoI sites of pwt(HX).
The constructs of the M1 series contain the Q227R
D243Y double mutation as described by Zavorotinskaya
and Albritton (1999). For this, the complementary oligo-
nucleotides 5MluI and 3MluI encoding the desired mu-
tations were inserted into the plasmid pwt(HX), replacing
the original env sequence between the BamH1 and PflMI
sites. This modification was then inserted as a XhoI/
PflMI fragment into the plasmids pEGF-Env, pEGF-TLDs-
Env, and pEGF(TLD/PRR), yielding the constructs pEGF-
EnvM1, pEGF-TLDs-EnvM1, and pEGF(TLD/PRRM1), re-
spectively. Plasmid pSFG-EGFP (Lindemann et al., 1997)
encodes the enhanced green fluorescence protein
(EGFP) as a reporter. It also encodes the MLV packaging
signal to measure transduction by MLV particles.
Transfections and transduction assays
Plasmids encoding the envelope glycoproteins were
transfected using the Superfect transfection reagent
(Qiagen, Hilden, Germany) according to the manufactur-
er’s instructions. For 10-cm dishes, Anjou 65 cells were
seeded at a density of 2  106 and transfected using 10
g total DNA. For six-well plates Anjou 65 cells were
seeded at a density of 0.5  106 and transfected with 2
g DNA. Two days after transfection, the supernatant
was collected, filtered through a 0.45-m pore filter (Mil-
lipore, Eschborn, Germany), and assayed. Target cells
were seeded in 12-well plates at a density of 5  104
cells per well the day before transduction. Viral super-
natant was added at various dilutions and incubated for
48 h. Transduction efficiency of the respective envelope
mutants was analyzed by monitoring the expression of
EGFP by fluorescence-activated cell sorting (FACScan,
Becton–Dickinson, Heidelberg) using the Cellquest soft-
ware.
Preparation of viral proteins and immunoblots
The analysis of incorporation of Env proteins into the
viral particles was performed by seeding 2.5 106 Anjou
65 cells and transfection the next day. The supernatants
of day 1, 2, and 3 were pooled, filtered through a 0.45-m
filter (Greiner, Frickenhausen, Germany), and stored at
80°C. Virus particles were pelleted through a 30%
sucrose cushion for 90 min at 26,000 rpm in an SW28
rotor. The pellet was resuspended in 50 l SDS loading
buffer (Laemli, 1970) and 15 l were analyzed. For cellu-
lar lysates, 106 cells were lysed in 50 l SDS loading
buffer and 15 l were analyzed. Viral proteins were
separated by electrophoresis through a 7.5% polyacryl-
amide gel and electroblotted onto a nitrocellulose trans-
fer membrane (Schleicher & Schuell, Dassel, Germany).
Immunostaining was performed in Tris base saline (pH
7.4) with 5% milk powder and 0.1% Tween 20. Envelope
proteins were detected by incubation with goat anti-
serum against p70 (Quality Biotech, Camden, NJ), fol-
lowed by an incubation with a horseradish peroxidase
labeled anti-goat antibody. Protein bands were finally
visualized by enhanced chemiluminescence detection
using the ECL kit (Amersham, Braunschweig, Germany)
according to the manufacturer’s instructions.
EGFR binding assay
A431 or COS-7 cells were incubated with serum-free
supernatant from the transfected packaging cells for 10
min at 37°C. Cells were then detached with EDTA and
lysed in lysis buffer (10% NP-40, 1 M Tris pH 7.5, 0.25 M
EGTA pH 8.0, 5 M NaCl). An amount of 50 g of cellular
proteins was analyzed by Western blot analysis. Phos-
phorylated EGFR was detected using a mouse monoclo-
nal antibody which is directed against phosphorylated
tyrosines (New England BioLabs, Schwalbach, Ger-
many). To investigate whether the binding of EGF-con-
taining Env mutants to EGFR could be blocked by an
anti-EGFR antibody, cells were preincubated with hu-
manized mouse monoclonal anti-EGFR antibody C225
(Fan and Mendelsohn, 1998) in a dilution of 1:1000 for 5
min, before vector-containing supernatant was added. To
analyze the total amount of EGFR present on these cells,
the blot was incubated with a rabbit anti-EGFR antibody
(Gullick, 1991).
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